INVENTURUS KNOWLEDGE SOLUTIONS LIMITED — Regulatory Filings 2026

May 13, 2026

IKS HEALTH

May 13, 2026

BSE Limited
The Listing Department
Phiroze Jeejeebhoy Towers
25th Floor, Dalal Street
Fort, Mumbai 400 001
Maharashtra, India
BSE Scrip Code: 544309

National Stock Exchange of India Limited
The Listing Department
Exchange Plaza, Plot No. C/1, G Block,
Bandra Kurla Complex
Bandra (East), Mumbai 400051
Maharashtra, India
NSE Symbol: IKS

Dear Sir/Ma’am,

Sub: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Outcome of the Board Meeting held on May 13, 2026.

Pursuant to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI LODR Regulations”), we hereby inform that the Board of Directors of Inventurus Knowledge Solutions Limited (“the Company”) at its meeting held today, i.e., May 13, 2026, inter alia, approved the following:

1. Financial Results:

The audited standalone and consolidated financial results of the Company for the quarter and financial year ended March 31, 2026 (“Financial Results”). The Financial Results and report issued by Price Waterhouse Chartered Accountants LLP, Statutory Auditor’s on the said Financial Results are enclosed as “Annexure – A”.

The Statutory Auditors have issued their Audit Reports on the Financial Results with an unmodified opinion. A Declaration from the Company to that effect is also enclosed as “Annexure - B”.

1. Change in Senior Management Personnel:

Pursuant to Regulation 30 of the SEBI LODR Regulations, we hereby inform you about change in Senior Management Personnel (“SMP”) of the Company with effect from May 14, 2026.

The relevant disclosures as required under Regulation 30 of the SEBI LODR Regulations and Part A of Schedule III thereof, read with SEBI Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 (Master Circular for compliance with the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 by listed entities) dated January 30, 2026 is enclosed herewith as “Annexure -C”.

1. Re-appointment of Internal Auditor:

The re-appointment of M/s KKC & Associates LLP, Chartered Accountants (Firm Registration Number – 105146W / W100621) as Internal Auditor of the Company, for the internal audit period covering the financial year 2026-27.

M/s. Inventurus Knowledge Solutions Limited
801, Building No. 5 & 6, 8th Floor, Mindspace Business Park (SEZ), Thane - Belapur Road, Airoli, Navi Mumbai - 400 708, Thane, Maharashtra, India. | Board: +91 22 3071 1100 | Fax: 91 22 6646 6879 | info@ikshealth.in | www.ikshealth.com
Registered Address: 801, Building No. 5 & 6, 8th Floor, Mindspace Business Park (SEZ), Thane - Belapur Road, Airoli, Navi Mumbai - 400 708, Thane, Maharashtra, India. CIN: L72200MH2006PLC337651

---

HKS

The relevant disclosures as required under Regulation 30 of the SEBI LODR Regulations and Part A of Schedule III thereof, read with SEBI Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 (Master Circular for compliance with the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 by listed entities) dated January 30, 2026 is enclosed herewith as Annexure – D.

4. Acquisition of Arai Solutions Private Limited:

The acquisition of 100% (one hundred percent) of the share capital in Arai Solutions Private Limited, a private limited company incorporated under the laws of India and having its registered office at D-37, Golden Enclave, Airport Road, Vimanapura, Bangalore, Karnataka, 560017, India (the “Target”) for a total cash consideration of INR 11,00,00,000 (Indian Rupees Eleven Crores only) (such acquisition, the “Proposed Acquisition”), and in connection with the same, has approved the execution of a share purchase agreement to be entered into by the Company, with the Target, Mr. Roland Erik Haas and Mr. Asoke Kumar Talukder and all such other agreements, deeds, documents, and instruments as may be required to be executed by the Company in connection with the Proposed Acquisition.

Upon completion of the Proposed Acquisition, the Target shall become a wholly-owned subsidiary of the Company.

The Board Meeting commenced at 05:15 P.M. IST and concluded at 06:39 P.M. IST.

The aforementioned information is also available on the Company’s website at https://ikshealth.com/investor-relations/.

We request you to take the same on your records

Yours sincerely,

For Inventurus Knowledge Solutions Limited

Sameer S Chavan
Digitally signed by
Sameer S Chavan
Date: 2026.05.13
19:35:42 +05'30'

Sameer Chavan
Company Secretary and Compliance Officer
Membership No. F7211

Encl: As above

M/s. Inventurus Knowledge Solutions Limited
801, Building No. 5 & 6, 8th Floor, Mindspace Business Park (SEZ), Thane - Belapur Road, Airoli, Navi Mumbai - 400 708, Thane, Maharashtra, India. | Board: +91 22 3071 1100 | Fax: 91 22 6646 6879 | info@ikshealth.in | www.ikshealth.com
Registered Address: 801, Building No. 5 & 6, 8th Floor, Mindspace Business Park (SEZ), Thane - Belapur Road, Airoli, Navi Mumbai - 400 708, Thane, Maharashtra, India. CIN: L72200MH2006PLC337651

---

Annexure - A

Price Waterhouse Chartered Accountants LLP

Independent Auditor's Report

To the Board of Directors of Inventurus Knowledge Solutions Limited

Report on the Audit of the Consolidated Financial Results

Opinion

1. We have audited the accompanying consolidated annual financial results of Inventurus Knowledge Solutions Limited (the “Holding Company”) and its subsidiaries (Holding Company and its subsidiaries together referred to as “the Group”) and its associate (refer Note 8 to the consolidated annual financial results) for the year ended March 31, 2026 and the consolidated statement of assets and liabilities as on that date and the consolidated statement of cash flows for the year ended on that date, attached herewith, which are included in the accompanying ‘Statement of audited financial results for the year ended March 31, 2026’ (the “consolidated financial results”) being submitted by the Holding Company pursuant to the requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (the “Listing Regulations”) which has been digitally signed by us only for identification purposes.

2. In our opinion and to the best of our information and according to the explanations given to us and based on the consideration of reports of other auditors on separate audited financial statements of the subsidiaries, the aforesaid consolidated financial results:

(i) include the annual financial results of the following entities:

Relationship	Entity name
Wholly owned Subsidiaries	Inventurus Knowledge Solutions Inc
IKS Cares Foundation
Step down Subsidiaries	Aquity Holdings Inc
Aquity Solutions LLC
Aquity Solutions India Private Limited
Aquity Solutions Australia Pty Limited
Aquitv Canada ULC
IKS Next Horizon Inc
Associate	IKS WWMG MSO, LLC

(ii) are presented in accordance with the requirements of Regulation 33 of the Listing Regulations in this regard; and

(iii) give a true and fair view in conformity with the recognition and measurement principles laid down in the applicable Indian Accounting Standards prescribed under Section 133 of the Companies Act, 2013 (the “Act”) and other accounting principles generally accepted in India, of net profit and other comprehensive income and other financial information of the Group and its associate for the year ended March 31, 2026 and the consolidated statement of assets and liabilities and the consolidated statement of cash flows as at and for the year ended on that date.

Price Waterhouse Chartered Accountants LLP, 252, Veer Savarkar Marg, Shivaji Park, Dadar (West), Mumbai - 400 028

T: +91 (22) 66697510

Registered office and Head office: 11-A, Vishnu Digamber Marg, Sucheta Bhawan, New Delhi - 110002

Price Waterhouse (a Partnership Firm) converted into Price Waterhouse Chartered Accountants LLP (a Limited Liability Partnership with LLP identity no: LLPIN AAC-5001) with effect from July 25, 2014. Post its conversion to Price Waterhouse Chartered Accountants LLP, its ICAI registration number is 012754N/N500016 (ICAI registration number before conversion was 012754N)

---

Price Waterhouse Chartered Accountants LLP

Independent Auditor's Report

To the Board of Directors of Inventurus Knowledge Solutions Limited

Report on the Audit of the Consolidated Financial Results

Page 2 of 5

Basis for Opinion

1. We conducted our audit in accordance with the Standards on Auditing (SAs) specified under Section 143(10) of the Act and other applicable authoritative pronouncements issued by the Institute of Chartered Accountants of India. Our responsibilities under those Standards are further described in the 'Auditor's Responsibilities for the Audit of the Consolidated Financial Results' section of our report. We are independent of the Group and its associate in accordance with the Code of Ethics issued by the Institute of Chartered Accountants of India together with the ethical requirements that are relevant to our audit of the financial statements under the provisions of the Act and the Rules thereunder, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the Code of Ethics. We believe that the audit evidence obtained by us and the other auditors in terms of their reports referred to in 'Other Matter' paragraph below, is sufficient and appropriate to provide a basis for our opinion.

Board of Directors' Responsibilities for the Consolidated Financial Results

1. These consolidated financial results have been prepared on the basis of the consolidated annual financial statements. The Holding Company's Board of Directors are responsible for the preparation and presentation of these consolidated financial results that give a true and fair view of the net profit and other comprehensive income and other financial information of the Group including its associate and the consolidated statement of assets and liabilities and the consolidated statement of cash flows in accordance with the recognition and measurement principles laid down in the Indian Accounting Standards prescribed under Section 133 of the Act read with relevant rules issued thereunder and other accounting principles generally accepted in India and in compliance with Regulation 33 of the Listing Regulations. The respective Board of Directors of the companies included in the Group and of its associate are responsible for maintenance of adequate accounting records in accordance with the provisions of the Act for safeguarding of the assets of the Group and its associate and for preventing and detecting frauds and other irregularities; selection and application of appropriate accounting policies; making judgments and estimates that are reasonable and prudent; and the design, implementation and maintenance of adequate internal financial controls, that were operating effectively for ensuring accuracy and completeness of the accounting records, relevant to the preparation and presentation of the consolidated financial statements that give a true and fair view and are free from material misstatement, whether due to fraud or error, which have been used for the purpose of preparation of the consolidated financial results by the Directors of the Holding Company, as aforesaid.

2. In preparing the consolidated financial results, the respective Board of Directors of the companies included in the Group and of its associate are responsible for assessing the ability of the respective companies to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the respective Board of Directors either intends to liquidate the respective companies or to cease operations, or has no realistic alternative but to do so.

3. The respective Board of Directors of the companies included in the Group and of its associate are responsible for overseeing the financial reporting process of the respective companies.

Auditor's Responsibilities for the Audit of the Consolidated Financial Results

1. Our objectives are to obtain reasonable assurance about whether the consolidated financial results as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with SAs will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these consolidated financial results.

---

Independent Auditor's Report

Report on the Audit of the Consolidated Financial Results

Page 3 of 5

1. As part of an audit in accordance with SAs, we exercise professional judgment and maintain professional scepticism throughout the audit. We also:

2. Identify and assess the risks of material misstatement of the consolidated financial results, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.

3. Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances. Under Section 143(3)(i) of the Act, we are also responsible for expressing our opinion on whether the Holding Company has adequate internal financial controls with reference to financial statements in place and the operating effectiveness of such controls.

4. Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by the Board of Directors.

5. Conclude on the appropriateness of the Board of Directors use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the ability of the Group and its associate to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor's report to the related disclosures in the consolidated financial results or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor's report. However, future events or conditions may cause the Group and its associate to cease to continue as a going concern.

6. Evaluate the overall presentation, structure and content of the consolidated financial results, including the disclosures, and whether the consolidated financial results represent the underlying transactions and events in a manner that achieves fair presentation.

7. Obtain sufficient appropriate audit evidence regarding the financial information of the entities within the Group and its associate to express an opinion on the consolidated financial results. We are responsible for the direction, supervision and performance of the audit of financial information of such entities included in the consolidated financial results of which we are the independent auditors. For the other entities included in the consolidated financial results, which have been audited by other auditors, such other auditors remain responsible for the direction, supervision and performance of the audits carried out by them. We remain solely responsible for our audit opinion.

8. We communicate with those charged with governance of the Holding Company regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.

9. We also provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding independence, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and where applicable, related safeguards.

10. We also performed procedures in accordance with the circular issued by the SEBI under Regulation 33(8) of the Listing Regulations, as amended, to the extent applicable.

---

Independent Auditor's Report
To the Board of Directors of Inventurus Knowledge Solutions Limited
Report on the Audit of the Consolidated Financial Results
Page 4 of 5

Other Matter

1. The financial statements of one subsidiary included in the consolidated financial results, reflect total assets of Rs. 3.86 million and net assets of Rs. 2.29 million as at March 31, 2026, total revenue of Rs. 19.52 million, net profit after tax of Rs. 1.94 million, and total comprehensive income (comprising of profit and other comprehensive income) of Rs. 1.94 million and net cash flows of Rs. (0.62) million for the year ended March 31, 2026, as considered in the consolidated financial results. The financial statements of this subsidiary has been audited by other auditors whose report has been furnished to us by the Holding Company's management, and our opinion on the consolidated financial results, insofar as it relates to the amounts and disclosures included in respect of this subsidiary, is based on the reports of the other auditors and the procedures performed by us as stated in paragraph 11 above.

2. The financial statements of one step down subsidiary included in the consolidated financial results, reflect total assets of Rs. 2,466.12 million and net assets of Rs. 1,914.27 million as at March 31, 2026, total revenue of Rs. 2,065.15 million, net profit after tax of Rs. 240.62 million, and total comprehensive income (comprising of profit and other comprehensive income) of Rs. 232.14 million and net cash flows of Rs. (36.74) million for the year ended March 31, 2026, as considered in the consolidated financial results. The financial statements of this step down subsidiary has been audited by other auditors whose report has been furnished to us by the Holding Company's management, and our opinion on the consolidated financial results, insofar as it relates to the amounts and disclosures included in respect of this step down subsidiary, is based on the reports of the other auditors and the procedures performed by us as stated in paragraph 11 above.

3. The consolidated financial results include the unaudited financial information of one step down subsidiary, whose financial information reflect total assets of Rs. 0.0001 million and net assets of Rs. 0.0001 million as at March 31, 2026, total revenue of Rs. nil, net profit after tax of Rs. nil, and total comprehensive income (comprising of profit and other comprehensive income) of Rs. nil and net cash flows of Rs. 0.0001 million for the year ended March 31, 2026, as considered in the consolidated financial results. The consolidated financial results also include the Group's share of net loss after tax of Rs. 112.65 million and total comprehensive loss (comprising of loss and other comprehensive loss) of Rs. 112.65 million for the year ended March 31, 2026, as considered in the consolidated financial results, in respect of one associate, whose financial information has not been audited by us. The financial information of this step down subsidiary and associate are unaudited and have been furnished to us by the Holding Company's management, and our opinion on the consolidated financial results, insofar as it relates to the amounts and disclosures included in respect of this step down subsidiary and associate, is based solely on such unaudited financial information. In our opinion and according to the information and explanations given to us by the Holding Company's management, these financial information are not material to the Group.

Our opinion on the consolidated financial results is not modified in respect of the above matters with respect to our reliance on the work done and the reports of the other auditors and the financial information certified by the management.

Page 5 of 5

1. The consolidated financial results include the results for the quarter ended March 31, 2026 being the balancing figures between the audited figures in respect of the full financial year and the published unaudited year to date figures up to the third quarter of the current financial year, which were subject to limited review by us.

For Price Waterhouse Chartered Accountants LLP

Firm Registration Number: 012754N/N500016

ALI

AKBAR

Digitally signed
by ALI AKBAR
Date: 2026.05.13
19:17:45 +05'30'

Alice Aki
Partner
Membership Number: 117839
UDIN: 26117839XJQEGE4489

Place: Mumbai
Date: May 13, 2026

Independent Auditor’s Report

Report on the Audit of the Standalone Financial Results

Opinion

1. We have audited the accompanying standalone annual financial results of Inventurus Knowledge Solutions Limited (the “Company”) for the year ended March 31, 2026 and the standalone statement of assets and liabilities as on that date and the standalone statement of cash flows for the year ended on that date, attached herewith, which are included in the accompanying ‘Statement of audited financial results for year ended March 31, 2026’ (together referred to as the “standalone financial results”) being submitted by the Company pursuant to the requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (the “Listing Regulations”) which has been digitally signed by us only for identification purposes.

2. In our opinion and to the best of our information and according to the explanations given to us, the standalone financial results:

(i) are presented in accordance with the requirements of Regulation 33 of the Listing Regulations in this regard; and

(ii) give a true and fair view in conformity with the recognition and measurement principles laid down in the applicable Indian Accounting Standards prescribed under Section 133 of the Companies Act, 2013 (the “Act”) and other accounting principles generally accepted in India, of net profit and other comprehensive loss and other financial information of the Company for the year ended March 31, 2026 and the standalone statement of assets and liabilities and the standalone statement of cash flows as at and for the year ended on that date.

Basis for Opinion

1. We conducted our audit in accordance with the Standards on Auditing (SAs) specified under Section 143(10) of the Act and other applicable authoritative pronouncements issued by the Institute of Chartered Accountants of India. Our responsibilities under those Standards are further described in the ‘Auditor’s Responsibilities for the Audit of the Standalone Financial Results’ section of our report. We are independent of the Company in accordance with the Code of Ethics issued by the Institute of Chartered Accountants of India together with the ethical requirements that are relevant to our audit of the financial statements under the provisions of the Act and the Rules thereunder, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the Code of Ethics. We believe that the audit evidence obtained by us is sufficient and appropriate to provide a basis for our opinion.

Board of Directors’ Responsibilities for the Standalone Financial Results

1. These standalone financial results have been prepared on the basis of the standalone annual financial statements. The Company’s Board of Directors are responsible for the preparation and presentation of these standalone financial results that give a true and fair view of the net profit and other comprehensive loss and other financial information of the Company and the standalone statement of assets and liabilities and the standalone statement of cash flows in accordance with the recognition and measurement principles laid down in the Indian Accounting Standards prescribed under Section 133 of the Act read with relevant rules issued thereunder and other accounting principles generally accepted in India and in compliance with Regulation 33 of the Listing Regulations. The Board of Directors of the Company are responsible for maintenance of

Price Waterhouse Chartered Accountants LLP, 252, Veer Savarkar Marg, Shivaji Park, Dadar (West), Mumbai - 400 028

T: +91 (22) 66697510

Registered office and Head office: 11-A, Vishnu Digamber Marg, Sucheta Bhawan, New Delhi - 110002

Price Waterhouse (a Partnership Firm) converted into Price Waterhouse Chartered Accountants LLP (a Limited Liability Partnership with LLP identity no: LLPIN AAC-5001) with effect from July 25, 2014. Post its conversion to Price Waterhouse Chartered Accountants LLP, its ICAI registration number is 012754N/N500016 (ICAI registration number before conversion was 012754N)

Page 2 of 3

Report on the Audit of the Standalone Financial Results

adequate accounting records in accordance with the provisions of the Act for safeguarding of the assets of the Company and for preventing and detecting frauds and other irregularities; selection and application of appropriate accounting policies; making judgments and estimates that are reasonable and prudent; and the design, implementation and maintenance of adequate internal financial controls, that were operating effectively for ensuring accuracy and completeness of the accounting records, relevant to the preparation and presentation of the standalone financial statements that give a true and fair view and are free from material misstatement, whether due to fraud or error, which have been used for the purpose of preparation of the standalone financial results by the Directors of the Company, as aforesaid.

1. In preparing the standalone financial results, the Board of Directors of the Company are responsible for assessing the ability of the Company to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the Board of Directors either intends to liquidate the Company or to cease operations, or has no realistic alternative but to do so.

2. The Board of Directors of the Company are responsible for overseeing the financial reporting process of the Company.

Auditor's Responsibilities for the Audit of the Standalone Financial Results

1. Our objectives are to obtain reasonable assurance about whether the standalone financial results as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with SAs will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these standalone financial results.

2. As part of an audit in accordance with SAs, we exercise professional judgment and maintain professional scepticism throughout the audit. We also:

3. Identify and assess the risks of material misstatement of the standalone financial results, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.

4. Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances. Under Section 143(3)(i) of the Act, we are also responsible for expressing our opinion on whether the company has adequate internal financial controls with reference to financial statements in place and the operating effectiveness of such controls.

5. Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by the Board of Directors.

6. Conclude on the appropriateness of the Board of Directors use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the ability of the Company to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor's report to the related disclosures in the standalone financial results or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor's report. However, future events or conditions may cause the Company to cease to continue as a going concern.

Page 3 of 3

• Evaluate the overall presentation, structure and content of the standalone financial results, including the disclosures, and whether the standalone financial results represent the underlying transactions and events in a manner that achieves fair presentation.

• We communicate with those charged with governance of the Company regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.

• We also provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding independence, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and where applicable, related safeguards.

Other Matter

1. The standalone financial results include the results for the quarter ended March 31, 2026 being the balancing figures between the audited figures in respect of the full financial year and the published unaudited year to date figures up to the third quarter of the current financial year, which were subject to limited review by us.

For Price Waterhouse Chartered Accountants LLP

Firm Registration Number: 012754N/N500016

ALI

AKBAR

Digitally signed

by ALI AKBAR

Date: 2026.05.13

19:18:18 +05'30"

Ali Akbar

Partner

Membership Number: 117839

UDIN: 26117839ZFRILJ7455

Place: Mumbai

Date: May 13, 2026

Inventurus Knowledge Solutions Limited Registered office: 801, Building No 5&6 8th floor, Mindspace Business Park (SEZ), Thane Belapur Road, Airoli, Navi Mumbai - 400 708, Thane, Maharashtra, India. CIN - L72200MH2006PLC337651 Telephone: +91 22 3964 3205 Website: www.ikshealth.com Email: : investor_relations@ikshealth.com Statement of audited financial results for the year ended March 31, 2026 (Amounts in INR/₹ Million, unless otherwise stated)
Sr.No	Particulars	Consolidated					Standalone
		For the Quarter ended			For the year ended		For the Quarter ended			For the year ended
		March 31, 2026 (Refer note 3)	December 31, 2025	March 31, 2025 (Refer note 3)	March 31, 2026	March 31, 2025	March 31, 2026 (Refer note 3)	December 31, 2025	March 31, 2025 (Refer note 3)	March 31, 2026	March 31, 2025
1	INCOME	unaudited	unaudited	unaudited	audited	audited	unaudited	unaudited	unaudited	audited	audited
	Revenue from operations	8,576.52	8,149.50	7,239.56	31,937.88	26,639.94	4,126.91	4,035.28	2,903.67	14,913.79	9,730.83
	Other income	48.73	55.53	32.61	171.94	389.98	14.53	18.81	16.92	71.58	153.17
	Total income	8,625.25	8,205.03	7,272.17	32,109.82	27,029.92	4,141.44	4,054.09	2,920.59	14,985.37	9,884.00
2	EXPENSES
	Changes in inventories of stock-in-trade	13.91	-	-	13.91	7.47	-	-	-	-	-
	Employee benefit expenses	4,183.63	4,059.09	3,865.50	16,272.84	14,946.06	1,747.45	1,657.01	1,186.45	6,323.83	4,321.99
	Finance cost	126.77	233.43	210.19	702.48	897.65	36.56	33.39	25.24	121.75	109.08
	Depreciation and amortisation expenses	340.57	320.47	283.33	1,241.50	1,126.63	109.63	99.47	72.91	373.39	288.58
	Other expenses	1,376.74	1,274.38	1,112.30	4,737.72	3,989.29	264.30	415.53	427.83	1,236.06	1,144.63
Total expenses	6,041.62	5,887.37	5,471.32	22,968.45	20,967.10	2,157.94	2,205.40	1,712.43	8,055.03	5,864.28
3	Profit before share of profit/(loss) from associates and tax (1-2)	2,583.63	2,317.66	1,800.85	9,141.37	6,062.82	1,983.50	1,848.69	1,208.16	6,930.34	4,019.72
	Share of profit/(loss) from associates accounted for using the equity method (net of tax)	(54.08)	(23.96)	-	(92.22)	-	-	-	-	-	-
5	Profit before tax (3+4)	2,529.55	2,293.70	1,800.85	9,049.15	6,062.82	1,983.50	1,848.69	1,208.16	6,930.34	4,019.72
	Tax Expenses
6	Current tax	295.88	520.16	163.97	2,003.69	1,247.55	370.86	339.02	211.57	1,249.26	700.22
	Deferred tax	173.99	(59.74)	158.86	(170.08)	(45.32)	(77.41)	47.27	(1.52)	15.89	0.02
	Total tax Expenses	469.87	460.42	322.83	1,833.61	1,202.23	293.45	386.29	210.05	1,265.15	700.24
	Profit for the period / year (5-6)	2,059.68	1,833.28	1,478.02	7,215.54	4,860.59	1,690.05	1,462.40	998.11	5,665.19	3,319.48

The statutory auditor has digitally signed the statement for identification purpose only and this statement should be read in conjunction with their report dated May 13, 2026.

Inventurus Knowledge Solutions Limited Registered office: 801, Building No 5&6 8th floor, Mindspace Business Park (SEZ), Thane Belapur Road, Airoli, Navi Mumbai - 400 708, Thane, Maharashtra, India. CIN - L72200MH2006PLC337651 Telephone: +91 22 3964 3205 Website: www.ikshealth.com Email: : investor_relations@ikshealth.com Statement of audited financial results for the year ended March 31, 2026 (Amounts in INR/₹ Million, unless otherwise stated)
Sr.No	Particulars	Consolidated					Standalone
		For the Quarter ended			For the year ended		For the Quarter ended			For the year ended
		March 31, 2026 (Refer note 3)	December 31, 2025	March 31, 2025 (Refer note 3)	March 31, 2026	March 31, 2025	March 31, 2026 (Refer note 3)	December 31, 2025	March 31, 2025 (Refer note 3)	March 31, 2026	March 31, 2025
		unaudited	unaudited	unaudited	audited	audited	unaudited	unaudited	unaudited	audited	audited
8	Other Comprehensive Income
	Items that may be reclassified to profit or loss
	Gains/ (losses) on cash flow hedges (net)	(519.28)	(32.17)	179.93	(856.30)	(39.42)	(523.09)	(38.38)	156.57	(855.10)	(40.62)
	Exchange differences on translation of financial statements of foreign operations	880.93	221.59	(30.60)	1,617.53	217.59	-	-	-	-	-
	Income tax relating to above items	107.80	6.56	(27.77)	178.37	6.88	108.76	8.12	(22.46)	178.37	6.88
	Items that will not be reclassified to profit or loss	469.45	195.98	121.56	939.60	185.05	(414.33)	(30.26)	134.11	(676.73)	(33.74)
	Remeasurement of post employment benefit obligations	3.95	(0.04)	(2.44)	(31.55)	(18.15)	3.88	(2.32)	(2.44)	(20.01)	(13.66)
	Changes in the fair value of equity investments at FVOCI	-	-	689.35	931.52	691.40	-	-	-	-	-
	Income tax relating to above items	28.89	1.50	(178.72)	(206.53)	(176.69)	(1.09)	0.64	0.51	5.36	2.54
		32.84	1.46	508.19	693.44	496.56	2.79	(1.68)	(1.93)	(14.65)	(11.12)
	Other Comprehensive Income / (loss) for the period / year, net of tax	502.29	197.44	629.75	1,633.04	681.61	(411.54)	(31.94)	132.18	(691.38)	(44.86)
Total Comprehensive Income for the period / year (7+8)	2,561.97	2,030.72	2,107.77	8,848.58	5,542.20	1,278.51	1,430.46	1,130.29	4,973.81	3,274.62
10	Paid-up equity share capital (Face value ₹ 1 per share)	170.71	170.60	170.23	170.71	170.23	170.71	170.60	170.23	170.71	170.23
11	Reserves excluding revaluation reserves as at balance sheet date				27,831.66	17,726.70				17,713.67	12,100.04
12	Earnings per share (Nominal value of share ₹ 1 each)
	Basic (INR per share)	12.31	10.96	8.88	43.12	29.20	10.10	8.74	6.00	33.85	19.94
	Diluted (INR per share)	12.06	10.73	8.70	42.26	28.62	9.90	8.56	5.88	33.18	19.54
The statutory auditor has digitally signed the statement for identification purpose only and this statement should be read in conjunction with their report dated May 13, 2026.

Inventurus Knowledge Solutions Limited
Registered office : 801, Building No 5&6 8th floor, Mindspace Business Park (SEZ),
Thane Belapur Road, Airoli, Navi Mumbai - 400 708, Thane, Maharashtra, India.
CIN - L72200MH2006PLC337651 Telephone : +91 22 3964 3205
Website: www.ikshealth.com Email: : investor_relations@ikshealth.com

Notes to the Statement of Audited Consolidated and Standalone Financial Results for the year ended March 31, 2026

1. The above standalone financial results of Inventurus Knowledge Solutions Limited ("the Company") and consolidated financial results of the Company and its subsidiaries (collectively "the Group") and its interest in associate for the quarter and year ended March 31, 2026 were reviewed and recommended by the Audit Committee and approved by the Board of Directors in it's meeting held on May 13, 2026. The above results for the year ended March 31, 2026 have been audited by the Statutory Auditors of the Company in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended.

2. The statement has been prepared in accordance with the recognition and measurement principles laid down in the applicable Indian Accounting Standards ("Ind AS") as prescribed under Section 133 of the Companies Act, 2013, as amended, read with relevant rules thereunder.

3. The figures of the quarter ended March 31, 2026 and March 31, 2025 are balancing figures between audited figures in respect of the full financial year and the published year to date figures up to the third quarter of the respective financial years.

4. In the consolidated financial results, the net foreign exchange gain aggregating to ₹ 627.47 million for the year ended March 31, 2026 (year ended March 31, 2025 ₹ 37.97 million) and ₹ 352.07 million for the quarter ended March 31, 2026 (quarter ended March 31, 2025 : ₹ (23.67) million) has been netted off against Other expenses.

In the standalone financial results, the net foreign exchange gain aggregating to ₹ 447.32 million for the year ended March 31, 2026 (year ended March 31, 2025 ₹ 19.68 million) and ₹ 250.36 million for the quarter ended March 31, 2026 (quarter ended March 31, 2025 : ₹ (19.40) million) has been netted off against Other expenses.

These are exchange differences recognised in accordance with Ind AS 21 - The Effects of Changes in Foreign Exchange Rates. The net foreign exchange gain primarily relates to exchange differences arising on realisation and restatement of foreign currency denominated trade receivables and cash and bank balances. The Company follows a consistent net presentation of foreign exchange differences, irrespective of whether the impact results in a gain or a loss.

1. The Group operates in one reportable business segment which comprises a Care enablement platform providing technology enabled solutions to Healthcare providers. This in the context of Indian Accounting Standard (Ind AS 108) "Operating Segments", constitutes a single operating segment.

2. The Company has allotted 105,432 shares (quarter ended March 31, 2025 : 464,800 shares) for the quarter and 472,514 shares (year ended March 31, 2025 : 648,002 shares) for the year ended March 31, 2026 to eligible employees on exercise of Employee Stock options, in accordance with the terms and conditions of the IKS Employees Stock Options Plan 2022 named 'IKS Health - ESOP Policy 2022' as approved by the shareholders of the Company on April 22, 2022. Further, during the quarter and year ended March 31, 2026, the Company has granted 13,76,000 and 26,90,500 stock options respectively to eligible employees, as approved by the Nomination and Remuneration Committee.

3. Earnings per share for the interim periods are not annualised.

4. The consolidated financial results of the Group include the results of its subsidiary companies viz: Inventurus Knowledge Solutions Inc, IKS Cares Foundation and its step down subsidiary companies viz: Aquity Holdings Inc, Aquity Solutions LLC, Aquity Solutions India Private Limited, Aquity Solutions Australia Pty Limited, Aquity Canada ULC and IKS Next Horizon, Inc. From the quarter ended September 30, 2025 the consolidated financial results also includes share of profit/(loss) from IKS WWMG MSO LLC, being an associate company.

5. On November 21, 2025, the Government of India notified the four consolidated Labour Codes, replacing multiple existing labour laws. Based on the draft rules and available guidance, the Company has assessed the impact of the revised wage definition on its employee benefit obligations in accordance with Ind AS 19. This assessment has resulted in a one-time estimated increase in employee benefit provisions, which is not material and has been recognised under Employee Benefits Expense in the current period. The Company will continue to monitor the finalisation of the relevant Central and State Rules and will account for any additional impacts in the period in which such Rules or clarifications are notified.

6. On April 23, 2026, Inventurus Knowledge Solutions, Inc., a wholly-owned subsidiary of the Company incorporated in the United States, entered into a definitive agreement to acquire TruBridge, Inc. (NASDAQ: TBRG), a US-based provider of healthcare technology solutions for rural and community hospitals for an enterprise value of up to US$565 million. The acquisition is subject to customary conditions as specified in the agreement.

ALI
AABAR
ASSOCIATION
for
INTERNATIONAL
ACCOUNTING
EXCELLENCE

The statutory auditor has digitally signed the statement for identification purpose only and this statement should be read in conjunction with their report dated May 13, 2026.

Place : Mumbai
Date : May 13, 2026

For Inventurus Knowledge Solutions Limited
NITHYA
Digitally signed by
NITHYA
BALASUBRAMANIAN
Date: 2026.05.13
18:34:19 +05'30'
Nithya Balasubramanian
Whole Time Director & Chief Financial Officer
DIN - 10664861

Inventory Knowledge Solutions Limited
Registered office : 801, Building No 5&6 8th floor, Mindspace Business Park (SEZ),
Thane Belapur Road, Airoli, Navi Mumbai - 400 708, Thane, Maharashtra, India.
CIN - L72200MH2006PLC337651 Telephone : +91 22 3964 3205
Website: www.ikshealth.com Email: : investor_relations@ikshealth.com
Statement of assets and liabilities
(Amounts in INR/₹ Million, unless otherwise stated)

	Consolidated		Standalone
	As at March 31, 2026	As at March 31, 2025	As at March 31, 2026	As at March 31, 2025
	Audited	Audited	Audited	Audited
A ASSETS
Non-current assets
Property, plant and equipment	540.68	412.42	433.78	295.17
Capital work-in-progress	-	53.42	-	52.88
Right-of-use assets	924.23	828.15	815.35	610.13
Goodwill	13,258.42	11,972.63	-	-
Other intangible assets	4,699.42	4,687.31	211.95	101.94
Intangible assets under development	61.33	77.09	34.92	44.27
Financial assets
Investments	1,567.85	1,137.37	13,521.99	7,342.04
Loans	235.93	-	-	-
Trade receivables	1,931.45	216.54	558.44	-
Other financial assets	2,917.44	1,114.37	95.95	60.39
Current tax assets (net)	687.63	400.70	60.61	44.30
Deferred tax assets (net)	1,892.51	1,459.23	1,279.23	1,111.40
Other non-current assets	865.49	320.44	40.47	40.40
Total non-current assets	29,582.38	22,679.67	17,052.69	9,702.92
Current assets
Inventories	0.58	-	-	-
Financial assets
Investments	2,201.02	-	-	-
Trade receivables	5,644.82	5,320.59	3,963.94	3,087.80
Cash and cash equivalents	3,887.16	1,804.22	273.16	731.16
Other bank balances	1.38	118.82	1.29	116.26
Loans	-	-	-	177.90
Other financial assets	828.80	263.69	116.64	100.29
Contract assets	19.62	-	15.24	-
Other current assets	513.05	331.39	216.59	131.39
Total current assets	13,096.43	7,838.71	4,586.86	4,344.80
TOTAL ASSETS	42,678.81	30,518.38	21,639.55	14,047.72
B EQUITY AND LIABILITIES
Equity
Equity share capital	170.71	170.23	170.71	170.23
Other equity	27,831.66	17,726.70	17,713.67	12,100.04
Total equity	28,002.37	17,896.93	17,884.38	12,270.27
Liabilities
Non-current liabilities
Financial liabilities
Borrowings	2,749.90	5,092.72	-	-
Lease liabilities	789.14	774.59	741.44	655.76
Contract liabilities	-	16.61	-	1.06
Deferred tax liabilities (net)	1,102.90	1,324.91	-	-
Provisions	333.98	200.85	202.95	104.90
Total non-current liabilities	4,975.92	7,409.68	944.39	761.72
Current liabilities
Financial liabilities
Borrowings	3,656.77	2,457.67	106.59	-
Lease liabilities	329.34	231.25	254.65	109.39
Trade payables
a) total outstanding dues of micro enterprises and small enterprises	30.13	14.19	26.53	11.00
b) total outstanding dues other than micro enterprises and small enterprises	1,456.92	745.37	444.17	296.43
Other financial liabilities	992.96	72.60	973.85	38.70
Contract liabilities	128.40	1.11	1.17	1.11
Provisions	644.09	514.38	171.28	99.01
Current tax liabilities (net)	554.61	165.77	0.19	38.58
Other current liabilities	1,907.30	1,009.43	832.35	421.51
Total current liabilities	9,700.52	5,211.77	2,810.78	1,015.73
TOTAL LIABILITIES	14,676.44	12,621.45	3,755.17	1,777.45
TOTAL EQUITY AND LIABILITIES	42,678.81	30,518.38	21,639.55	14,047.72

IKS HEALTH

Annexure - B

May 13, 2026

BSE Limited
The Listing Department
Phiroze Jeejeebhoy Towers
25th Floor, Dalal Street
Fort, Mumbai 400 001
Maharashtra, India
BSE Scrip Code: 544309

National Stock Exchange of India Limited
The Listing Department
Exchange Plaza, Plot No. C/1, G Block,
Bandra Kurla Complex
Bandra (East), Mumbai 400051
Maharashtra, India
NSE Symbol: IKS

Dear Sir/Ma’am,

Sub: Declaration with respect to Financial Results

I, Nithya Balasubramanian, Whole-time Director & Chief Financial Officer of Inventurus Knowledge Solutions Limited hereby declare that Price Waterhouse Chartered Accountants LLP, Statutory Auditor’s of the Company have issued Audit Reports with unmodified opinion on the Financial Results of the Company (Standalone and Consolidated) for the year ended March 31, 2026.

The declaration is given pursuant to Regulation 33(3)(d) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended.

We request you to take the same on your records

Yours sincerely,

For Inventurus Knowledge Solutions Limited

NITHYA
Digitally signed by
NITHYA
BALASUBRAM
BALASUBRAMANIAN
ANIAN
Date: 2026.05.13
19:34:55 +05'30'

Nithya Balasubramanian
Whole-time Director & Chief Financial Officer

ANNEXURE - C

DISCLOSURE UNDER REGULATION 30 OF THE SEBI LODR REGULATIONS READ WITH SEBI CIRCULAR NO. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 DATED JANUARY 30, 2026

Disclosure of Change in Senior Management Personnel

Sr. No.	Particulars	Details
1.	Name of Senior Managerial Personnel	Saransh Mundra
2.	Reason for change viz. appointment, reappointment, resignation, removal, death or otherwise	Pursuant to a review of internal roles and responsibilities, Mr. Saransh Mundra will no longer be classified as Senior Management Personnel of the Company under the provisions of the Companies Act, 2013 and SEBI LODR Regulations. He remains an integral part of the organization and responsible for investor relations.
3.	Date of appointment/ reappointment/ cessation (as applicable) & term of appointment	Effective from May 14, 2026
4.	Brief profile (in case of appointment)	Not Applicable
5.	Disclosure of Relationship between Directors	None

M/s. Inventurus Knowledge Solutions Limited

801, Building No. 5 & 6, 8th Floor, Mindspace Business Park (SEZ), Thane - Belapur Road, Airoli, Navi Mumbai - 400 708, Thane, Maharashtra, India. | Board: +91 22 3071 1100 | Fax: 91 22 6646 6879 | info@ikshealth.in | www.ikshealth.com

Registered Address: 801, Building No. 5 & 6, 8th Floor, Mindspace Business Park (SEZ), Thane - Belapur Road, Airoli, Navi Mumbai - 400 708, Thane, Maharashtra, India.

CIN: L72200MH2006PLC337651

ANNEXURE - D

DISCLOSURE UNDER REGULATION 30 OF THE SEBI LODR REGULATIONS READ WITH SEBI CIRCULAR NO. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 DATED JANUARY 30, 2026

Disclosure of re-appointment of Internal Auditor

Sr. No.	Particulars	Details
1.	Name of the Internal Auditor	M/s KKC & Associates LLP, Chartered Accountants (Firm Registration Number – 105146W / W100621), as the Internal Auditors of the Company.
2.	Reason for Change viz. re-appointment	The Board has approved appointment of M/s KKC & Associates LLP, Chartered Accountants (Firm Registration Number – 105146W / W100621), as an Internal Auditor of the Company for internal audit period covering the financial year 2026-27.
3.	Date of appointment and term of appointment	The Board at its meeting held on May 13, 2026, approved the appointment of M/s KKC & Associates LLP, Chartered Accountants (Firm Registration Number – 105146W / W100621) for internal audit.
M/s KKC & Associates LLP, Chartered Accountants will do internal audit for period covering the financial year 2026-27.
4.	Brief Profile (in case of appointment)	KKC & Associates LLP is one of India’s leading chartered accountancy firms, with a heritage that dates back to 1936. Over the decades, KKC & Associates LLP built a strong presence across Mumbai, Bengaluru, Pune, and Ahmedabad, and today, our 350+ professionals and 18 partners support clients ranging from listed clients, MNCs, large enterprises, high-growth SMEs and owner-managed businesses.

M/s. Inventurus Knowledge Solutions Limited

801, Building No. 5 & 6, 8th Floor, Mindspace Business Park (SEZ), Thane - Belapur Road, Airoli, Navi Mumbai - 400 708, Thane, Maharashtra, India. | Board: +91 22 3071 1100 | Fax: 91 22 6646 6879 | info@ikshealth.in | www.ikshealth.com

Registered Address: 801, Building No. 5 & 6, 8th Floor, Mindspace Business Park (SEZ), Thane - Belapur Road, Airoli, Navi Mumbai - 400 708, Thane, Maharashtra, India. CIN: L72200MH2006PLC337651

ANNEXURE - E

Disclosure of Acquisition of Arai Solutions Private Limited

S. No.	Particulars	Description
1.	Name of the target entity, details in brief such as size, turnover etc.	(i) Name of the Target: Arai Solutions Private Limited (“Target”) (ii) Details of the Target: The Target is engaged in the business of providing consultancy services related to artificial intelligence solutions across industries, including in the healthcare space. Financial Details of the Target:
		Particulars FY 2025-26 Amt in INR
		Revenue from operations 5,462,600
		Other income 75,794
		Total income 5,538,394
		Net worth 956,433
2.	Whether the acquisition would fall within related party transaction(s) and whether the promoter/promoter group/ group companies have any interest in the entity being acquired? If yes, nature of interest and details thereof and whether the same is done at “arm’s length.	No, the acquisition does not constitute a related party transaction. The Promoter/ Promoter Group of the Company does not have any interest in the entity being acquired.
3.	Industry to which the entity being acquired belongs.	Information Technology Enabled Services (ITeS) industry. The Target is engaged in providing artificial intelligence solutions, across industries, including in the healthcare space.
4.	Objects and impact of acquisition (including but not limited to, disclosure of reasons for acquisition of target entity, if its business is outside the main line of business of the listed entity)	Given the Target’s expertise in applied research in AI-focused services (including software development), the acquisition enables the Company to enhance its existing capabilities and care management workflows as well as accelerate the Company’s AI R&D.

Thane, Maharashtra, India. | Board: +91 22 3071 1100 | Fax: 91 22 6646 6879 | info@ikshealth.in | www.ikshealth.com

CIN: L72200MH2006PLC337651

HKS

5.	Brief details of any governmental or regulatory approvals required for the acquisition	Not applicable.
6.	Indicative time period for completion of the acquisition.	By or before June 20, 2026.
7.	Consideration - whether cash consideration or share swap and details of the same	Cash consideration
8.	Cost of acquisition and/or the price at which the shares are acquired.	INR 11,00,00,000 (Indian Rupees Eleven Crores only)
1.	Percentage of shareholding / control acquired and / or number of shares acquired.	The Company will acquire 10,000 equity shares of INR 10/- each in the Target (constituting 100% of total paid-up share capital of the Target). Consequently, the Target will become a wholly owned subsidiary of the Company.
9.	Brief background about the entity acquired in terms of products/line of business acquired, date of incorporation, history of last 3 years turnover, country in which the acquired entity has presence and any other significant information (in brief).	(i) Brief background: Arai Solutions Private Limited (CIN: U58200KA2024PTC187134), a company incorporated under the laws of India and having its registered office at D-37, Golden Enclave, Airport Road, Vimanapura, Bangalore, Karnataka, 560017, India
(ii) Line of business: The Target is engaged in the business of (i) provision of consultancy services related to artificial intelligence solutions, including research and development activities in respect of algorithms and architectures, and the design of algorithms and solutions for deep learning, machine learning, generative artificial intelligence, large language models, natural language processing, symbolic artificial intelligence (including knowledge graphs and logic systems), and hybrid artificial intelligence solutions; (ii) the development of artificial intelligence solutions for cybersecurity; (iii) the development of neural networks and hybrid artificial intelligence systems, including hardware acceleration, parallel computing architectures, for training and inference in large-scale deep neural networks; and (iv) any activities ancillary to the foregoing.
(iii) Date of incorporation: April 5, 2024

PIKS HEALTH

	(iv) Turnover of last 3 years:
Year	Revenue (in INR)
2025-26	5,462,600
2024-25	550,555
2023-24	Not applicable, since the Target was incorporated on April 5, 2024

(v) Country in which the acquired entity has presence: India

---